John J. Canepa
Net Worth
Last updated:
What is John J. Canepa net worth?
The estimated net worth of Mr. John J. Canepa is at least $413,215 as of 29 Jul 2021. He owns shares worth $56,295 as insider and has received compensation worth at least $356,920 in Candel Therapeutics, Inc..
What is the salary of John J. Canepa?
Mr. John J. Canepa salary is $89,230 per year as Chief Financial Officer in Candel Therapeutics, Inc..
How old is John J. Canepa?
Mr. John J. Canepa is 69 years old, born in 1956.
What stocks does John J. Canepa currently own?
As insider, Mr. John J. Canepa owns shares in one company:
| Company | Title | Shares | Price per share | Total value |
|---|---|---|---|---|
| Candel Therapeutics, Inc. (CADL) | Chief Financial Officer | 10,125 | $5.56 | $56,295 |
What does Candel Therapeutics, Inc. do?
Candel Therapeutics, Inc., a clinical stage biopharmaceutical company, engages in the development immunotherapies for the cancer patients. The company develops CAN-2409, which is in Phase II clinical trails for the treatment of pancreatic cancer; Phase III clinical trials for the treatment of prostate cancer; and Phase II clinical trials for the treatment of lung cancer, as well as has completed Phase Ib/II clinical trials for the treatment of high-grade glioma. It also develops CAN-3110, which is in Phase I clinical trials for the treatment of recurrent glioblastoma. The company was formerly known as Advantagene, Inc. and changed its name to Candel Therapeutics, Inc. in November 2020. The company was incorporated in 2003 and is based in Needham, Massachusetts.
John J. Canepa insider trading
Candel Therapeutics key executives
Candel Therapeutics, Inc. executives and other stock owners filed with the SEC:
- Dr. Estuardo Aguilar-Cordova Inf., M.D., Ph.D. (67) Founder, Chief Scientific Officer & Director
- Dr. Laura K. Aguilar (60) Chief Medical Officer
- Dr. Paul-Peter Tak FMEDSCI, M.D., Ph.D. (65) Pres, Chief Executive Officer & Director
- Mr. John J. Canepa (69) Chief Financial Officer